- Home
- MRK
as 07-18-2025 4:00pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | RAHWAY |
| Market Cap: | 198.5B | IPO Year: | N/A |
| Target Price: | $112.57 | AVG Volume (30 days): | 17.0M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.88 | EPS Growth: | 667.14 |
| 52 Week Low/High: | $73.31 - $128.73 | Next Earning Date: | 07-29-2025 |
| Revenue: | $63,922,000,000 | Revenue Growth: | 4.10% |
| Revenue Growth (this year): | 2.26% | Revenue Growth (next year): | 5.79% |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 hours ago
Livestock Identification Company Evaluation Report 2025 | Merck, Shearwell, Datamars Drive Innovations with Comprehensive Tagging and Tracking Solutions
Insider Monkey
16 hours ago
Morgan Stanley Lowered the Firm’s PT on Merck & Co (MRK), Kept a Hold Rating
Insider Monkey
a day ago
Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment
Zacks
a day ago
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
Motley Fool
2 days ago
Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business
Barrons.com
2 days ago
Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.
Financial Times
2 days ago
Johnson & Johnson shares jump after forecasting sales boost and milder tariff impact
GlobeNewswire
2 days ago
Grignard Reagents Global Market Forecast Report 2025-2030 | Emergence of Green Chemistry and Sustainable Practices, & Rising Demand in Asia-Pacific Driving Multi-Billion Opportunities
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.